| Podcast
Per the department of Health and Human Services, opioid related overdose deaths have increased almost 400% over the last 18 years. This shift has yielded heightened scrutiny of prescribing practices, and opioids have subsequently fallen out of favor as a first-line treatment for chronic pain. In...
| Article
In terms of biopsychosocial treatment, providers must know that it’s critically important to look at all the factors that are affecting a patient’s pain condition. Any time we pigeonhole ourselves in any one category--whether it’s the medical piece, the psychological piece, or the physical piece--we...
| Article
Both the central nervous system and the peripheral nervous system are heavily involved in starting and continuing a migraine attack, and are involved before the migraine even starts. If you divide a migraine into premonitory phases–the aura, the migraine phase and then the postdrome, with modern...
| Article
I think we have to go back to before a lot of these scores, before the fifth vital sign was pain management. How did we treat patients before we had all these medications, interventions, surgeries at our disposal that were meant to help pain. I think a lot of what we're applying to chronic pain...
| Video
The movement to prescribing guidelines began in Washington State. Professor Zeigler summarizes where we've gone from there in the increasingly complex arena of guidelines, rules, and regulations, and what the overall impact has been on various dimensions of pain practice.
| Video
Dr. Ward discusses points of differential diagnosis and strategies for treatment selection that can promote better outcomes for migraine sufferers. The Migraine Treatment Optimization Questionnaire is a tool that can help the clinician address unmet needs for their patients.
| Video
The American Headache Society's chronic Migraine Education Program (CMEP) was presented as part of the curriculum at PAINWeek 2017. In the segment, panelist Kathleen Digre, MD, discusses the interaction of central and peripheral nervous systems in triggering a migraine attack, the longer-term...
| Video
Approximately 1 billion people in the world are affected by migraine, and some 40% are estimated to be candidates for preventative therapy. Dr. Vargas outlines some objectives and principles for treating this patient population. New medications and therapies on the horizon point to better outcomes...
| Video
Dr. Ziegler comments on the importance of documenting best practice compliance in today's environment of intense scrutiny and litigiousness. There are steps that clinicians can take today, and ways that they can influence the future of regulation and reimbursement.
| Video
A number of regulatory agencies are now "sitting at the pain management table" with the ability to impact clinical decisions regarding pain care. It is critical that the practitioner is able to navigate the waters without sacrificing the primary stakeholder: the patient. Dr. Zacharoff weighs in...